Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Storer

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Molecular Biosystems|March 30, 2016
Design and development of histone deacetylase (HDAC) chemical probes for cell-based profilingVictoria E Albrow, Rachel L Grimley, James Clulow, et al.
Journal of Chemical Information and Modeling|July 12, 2021
Delineating the Ligand-Receptor Interactions That Lead to Biased Signaling at the μ-Opioid ReceptorBrendan Kelly, Scott A Hollingsworth, David C Blakemore, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-METGavin W Collie, Iacovos N Michaelides, Kevin Embrey, et al.
Frontiers in Molecular Neuroscience|March 15, 2017
Discovery of Compounds that Positively Modulate the High Affinity Choline TransporterParul Choudhary, Emma J Armstrong, Csilla C Jorgensen, et al.
Journal of Medicinal Chemistry|November 6, 2012
Ion channels as therapeutic targets: a drug discovery perspectiveSharan K Bagal, Alan D Brown, Peter J Cox, et al.
ACS Medicinal Chemistry Letters|March 28, 2015
Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor AgonistsGuy Rouquet, Dianna E Moore, Malcolm Spain, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 22, 2025
Development of compounds for targeted degradation of mammalian cryptochrome proteinsJack Munns, Andrew D Beale, Iacovos N Michaelides, et al.
Journal of the American Chemical Society|July 30, 2025
Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug DiscoveryAndres R Gomez-Angel, Hanna F Klein, Stephen Y Yao, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Fragment-Based Discovery of Novel Allosteric MEK1 BindersPaolo Di Fruscia, Fredrik Edfeldt, Igor Shamovsky, et al.
RSC Medicinal Chemistry|November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment setSimon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Molecular Biosystems|March 30, 2016
Design and development of histone deacetylase (HDAC) chemical probes for cell-based profilingVictoria E Albrow, Rachel L Grimley, James Clulow, et al.
Journal of Chemical Information and Modeling|July 12, 2021
Delineating the Ligand-Receptor Interactions That Lead to Biased Signaling at the μ-Opioid ReceptorBrendan Kelly, Scott A Hollingsworth, David C Blakemore, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-METGavin W Collie, Iacovos N Michaelides, Kevin Embrey, et al.
Frontiers in Molecular Neuroscience|March 15, 2017
Discovery of Compounds that Positively Modulate the High Affinity Choline TransporterParul Choudhary, Emma J Armstrong, Csilla C Jorgensen, et al.
Journal of Medicinal Chemistry|November 6, 2012
Ion channels as therapeutic targets: a drug discovery perspectiveSharan K Bagal, Alan D Brown, Peter J Cox, et al.
ACS Medicinal Chemistry Letters|March 28, 2015
Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor AgonistsGuy Rouquet, Dianna E Moore, Malcolm Spain, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 22, 2025
Development of compounds for targeted degradation of mammalian cryptochrome proteinsJack Munns, Andrew D Beale, Iacovos N Michaelides, et al.
Journal of the American Chemical Society|July 30, 2025
Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug DiscoveryAndres R Gomez-Angel, Hanna F Klein, Stephen Y Yao, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Fragment-Based Discovery of Novel Allosteric MEK1 BindersPaolo Di Fruscia, Fredrik Edfeldt, Igor Shamovsky, et al.
RSC Medicinal Chemistry|November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment setSimon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
Pageof 5